Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a rare ... patients are aware that Novo Nordisk is the only company in the U.S. with FDA-approved medicines ...
A particular formulation of semaglutide is presenting hazards that a major pharmaceutical company is warning customers about.
Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...
Earlier, Novo Nordisk A/S (NYSE:NVO) petitioned the FDA to ban compounding pharmacies from producing cheaper, unapproved ...
At first, these medications were used to treat diabetes. But when the FDA finally gave pharmaceutical companies approval to ...
Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.